Brian Gardner

2.8k total citations
27 papers, 2.1k citations indexed

About

Brian Gardner is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Brian Gardner has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Pharmacology and 8 papers in Immunology. Recurrent topics in Brian Gardner's work include Inflammatory mediators and NSAID effects (8 papers), Cannabis and Cannabinoid Research (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Brian Gardner is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Cannabis and Cannabinoid Research (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Brian Gardner collaborates with scholars based in United States, France and Japan. Brian Gardner's co-authors include Sherven Sharma, Steven M. Dubinett, Li Zhu, Raj K. Batra, Karen L. Reckamp, Marina Stolina, Ying Lin, Min Huang, Mariam Dohadwala and Mitchell Kronenberg and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Brian Gardner

27 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Gardner United States 18 787 712 664 494 265 27 2.1k
Joseph P. Portanova United States 20 861 1.1× 610 0.9× 246 0.4× 473 1.0× 289 1.1× 27 2.1k
Nori Matsunami United States 20 922 1.2× 356 0.5× 380 0.6× 1.1k 2.2× 620 2.3× 26 2.8k
Marina Stolina United States 7 524 0.7× 506 0.7× 417 0.6× 218 0.4× 204 0.8× 11 1.2k
Linhua Pang United Kingdom 29 517 0.7× 434 0.6× 328 0.5× 866 1.8× 163 0.6× 46 2.5k
Fabio Benigni Italy 25 792 1.0× 185 0.3× 304 0.5× 610 1.2× 74 0.3× 73 2.0k
John B. Cheng United States 23 334 0.4× 413 0.6× 177 0.3× 1.1k 2.2× 141 0.5× 59 2.0k
Suchita Nadkarni United Kingdom 19 904 1.1× 170 0.2× 284 0.4× 636 1.3× 152 0.6× 41 2.0k
Péter Polgàr United States 29 324 0.4× 373 0.5× 226 0.3× 1.1k 2.2× 213 0.8× 117 2.6k
P Carayon France 28 704 0.9× 143 0.2× 400 0.6× 932 1.9× 312 1.2× 98 3.1k
M Fong United States 9 409 0.5× 181 0.3× 281 0.4× 497 1.0× 79 0.3× 12 1.5k

Countries citing papers authored by Brian Gardner

Since Specialization
Citations

This map shows the geographic impact of Brian Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Gardner more than expected).

Fields of papers citing papers by Brian Gardner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Gardner. The network helps show where Brian Gardner may publish in the future.

Co-authorship network of co-authors of Brian Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Gardner. A scholar is included among the top collaborators of Brian Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Gardner. Brian Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Draanen, Jenna van, Pamela L. Davidson, H Bour, et al.. (2016). Assessing Researcher Needs for a Virtual Biobank. Biopreservation and Biobanking. 15(3). 203–210. 17 indexed citations
2.
Liclican, Elvira L., Tonya C. Walser, Saswati Hazra, et al.. (2014). Loss of miR125a Expression in a Model of K-ras–Dependent Pulmonary Premalignancy. Cancer Prevention Research. 7(8). 845–855. 4 indexed citations
3.
Krysan, Kostyantyn, Xiaoyan Cui, Brian Gardner, et al.. (2013). Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer.. PubMed. 5(5). 481–96. 15 indexed citations
4.
Reckamp, Karen L., Marianna Koczywas, Mihaela Cristea, et al.. (2012). Randomized phase II trial of erlotinib (E) plus high-dose celecoxib (HD-C) or placebo (P) in advanced non-small cell lung cancer.. Journal of Clinical Oncology. 30(15_suppl). 7518–7518. 1 indexed citations
5.
Kim, Grace Hyun J., Anusha Kalbasi, Brian Gardner, et al.. (2011). A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases. Journal of Translational Medicine. 9(1). 43–43. 46 indexed citations
6.
Krysan, Kostyantyn, Jay M. Lee, Mariam Dohadwala, et al.. (2008). Inflammation, Epithelial to Mesenchymal Transition, and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance. Journal of Thoracic Oncology. 3(2). 107–110. 41 indexed citations
7.
Reckamp, Karen L., Brian Gardner, Robert A. Figlin, et al.. (2008). Tumor Response to Combination Celecoxib and Erlotinib Therapy in Non-small Cell Lung Cancer Is Associated with a Low Baseline Matrix Metalloproteinase-9 and a Decline in Serum-Soluble E-Cadherin. Journal of Thoracic Oncology. 3(2). 117–124. 46 indexed citations
8.
Sharma, Sherven, Li Zhu, Ling Zhang, et al.. (2005). Cyclooxygenase 2 Inhibition Promotes IFN-γ-Dependent Enhancement of Antitumor Responses. The Journal of Immunology. 175(2). 813–819. 55 indexed citations
9.
Mao, Jenny T., Xiaoyan Cui, Karen L. Reckamp, et al.. (2005). Chemoprevention Strategies with Cyclooxygenase-2 Inhibitors for Lung Cancer. Clinical Lung Cancer. 7(1). 30–39. 32 indexed citations
10.
Yang, Seok-Chul, Sven Hillinger, Karen Riedl, et al.. (2004). Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity. Clinical Cancer Research. 10(8). 2891–2901. 122 indexed citations
11.
Gardner, Brian. (2004). Bringing laptops to class. 7–12. 3 indexed citations
12.
Zhu, Li, Sherven Sharma, Brian Gardner, et al.. (2003). IL-10 Mediates Sigma1 Receptor-Dependent Suppression of Antitumor Immunity. The Journal of Immunology. 170(7). 3585–3591. 37 indexed citations
13.
Gardner, Brian, Li Zhu, Michael D. Roth, et al.. (2003). Cocaine modulates cytokine and enhances tumor growth through sigma receptors. Journal of Neuroimmunology. 147(1-2). 95–98. 31 indexed citations
14.
Huang, Min, Sherven Sharma, Li Zhu, et al.. (2002). IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis. Journal of Clinical Investigation. 109(7). 931–937. 110 indexed citations
15.
Huang, Min, Sherven Sharma, Li Zhu, et al.. (2002). IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis. Journal of Clinical Investigation. 109(7). 931–937. 124 indexed citations
16.
Gardner, Brian, Sherven Sharma, Qian Liu, et al.. (2002). Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-β. Biochemical and Biophysical Research Communications. 290(1). 91–96. 47 indexed citations
17.
Gardner, Brian & Neil D. Clarke. (2001). Helping faculty make technology a part of the curriculum. 44–44. 2 indexed citations
18.
Stolina, Marina, Sherven Sharma, Ying Lin, et al.. (2000). Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis. The Journal of Immunology. 164(1). 361–370. 397 indexed citations
19.
Batra, Raj K., et al.. (2000). Adenoviral Gene Transfer Is Inhibited by Soluble Factors in Malignant Pleural Effusions. American Journal of Respiratory Cell and Molecular Biology. 22(5). 613–619. 15 indexed citations
20.
Sharma, Sherven, Marina Stolina, Ying Lin, et al.. (1999). T Cell-Derived IL-10 Promotes Lung Cancer Growth by Suppressing Both T Cell and APC Function. The Journal of Immunology. 163(9). 5020–5028. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph P. Portanova Breakdown of academic impact, for papers by Nori Matsunami Breakdown of academic impact, for papers by Marina Stolina Breakdown of academic impact, for papers by Linhua Pang Breakdown of academic impact, for papers by Fabio Benigni Breakdown of academic impact, for papers by John B. Cheng Breakdown of academic impact, for papers by Suchita Nadkarni Breakdown of academic impact, for papers by Péter Polgàr Breakdown of academic impact, for papers by P Carayon Breakdown of academic impact, for papers by M Fong
Rankless by CCL
2026